Inventor · disambiguated record
Alain Moussy
Also filed as: MOUSSY ALAIN
27 granted patents·49 pending applications·94 citations·filing 2001–2022
94Inventor score
Top patents by PatentIndex Score
76 records- 0192US10092564B2Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulationAB SCIENCE·Filed 2017·Granted Oct 9, 2018·11 cites·20 claims
- 0289US8450302B22-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsCIUFOLINI MARCO·Filed 2011·Granted May 28, 2013·8 cites·7 claims
- 0388US7423055B22-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseasesAB SCIENCE·Filed 2003·Granted Sep 9, 2008·29 cites·30 claims
- 0487US7718676B22-aminoaryloxazole compounds as tyrosine kinase inhibitorsAB SCIENCE·Filed 2004·Granted May 18, 2010·31 cites·17 claims
- 0580US9078894B2Treatment of severe persistant asthma with masitinibMOUSSY ALAIN·Filed 2012·Granted Jul 14, 2015·2 cites·17 claims
- 0680US8227470B2Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitorsMOUSSY ALAIN·Filed 2008·Granted Jul 24, 2012·1 cites·17 claims
- 0773US8993573B22-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsAB SCIENCE·Filed 2013·Granted Mar 31, 2015·1 cites·10 claims
- 0873US8492545B2Aminothiazole compounds as kinase inhibitors and methods of using the sameMOUSSY ALAIN·Filed 2012·Granted Jul 23, 2013·2 cites·2 claims
- 0971US8835435B22-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsCIUFOLINI MARCO·Filed 2011·Granted Sep 16, 2014·1 cites·15 claims
- 1070US8153792B2Process for the synthesis of 2-aminothiazole compounds as kinase inhibitorsMOUSSY ALAIN·Filed 2008·Granted Apr 10, 2012·1 cites·22 claims
- 1166US8658659B2Substituted oxazole derivatives and their use as tyrosine kinase inhibitorsGRIERSON DAVID·Filed 2012·Granted Feb 25, 2014·2 cites·13 claims
- 1266US8110591B22-aminoaryloxazole compounds as tyrosine kinase inhibitorsMOUSSY ALAIN·Filed 2010·Granted Feb 7, 2012·1 cites·18 claims
- 1364US7727731B2Potent, selective and non toxic c-kit inhibitorsAB SCIENCE·Filed 2002·Granted Jun 1, 2010·2 cites·24 claims
- 1462US7700610B2Use of tyrosine kinase inhibitors for treating allergic diseasesAB SCIENCE·Filed 2002·Granted Apr 20, 2010·1 cites·2 claims
- 1562US7678805B2Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)AB SCIENCE·Filed 2002·Granted Mar 16, 2010·1 cites·4 claims
- 1660US2008255141A12-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsAB SCIENCE·Filed 2007·Application pending·0 cites
- 1758US2009082360A1Use of tyrosine kinase inhibitors for treating CNS disordersAB SCIENCE·Filed 2008·Application pending·0 cites
- 1858US2024016766A1Pharmaceutical composition for treatment of inner ear disorders through local administration in the tympanic areaMOUSSY ALAIN·Filed 2021·Application pending·0 cites
- 1957US8940894B2Aminothiazole compounds as kinase inhibitors and methods of using the sameAB SCIENCE·Filed 2013·Granted Jan 27, 2015·0 cites·3 claims
- 2056US2023321081A1Masitinib for the treatment of castrate-resistant prostate cancerAB SCIENCE·Filed 2022·Application pending·0 cites
- 2155US8906357B2Treatment of multiple sclerosis with masitinibMOUSSY ALAIN·Filed 2011·Granted Dec 9, 2014·0 cites·24 claims
- 2254US10238649B2Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factorsAB SCIENCE·Filed 2013·Granted Mar 26, 2019·0 cites·11 claims
- 2354US2005239852A12-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitorsAB SCIENCE·Filed 2003·Application pending·0 cites
- 2454US2024058328A1Masitinib for the treatment of alzheimer's diseaseAB SCIENCE·Filed 2021·Application pending·0 cites
- 2552US2023023935A1Use of masitinib for the treatment of eosinophilic asthmaAB SCIENCE·Filed 2020·Application pending·0 cites
- 2652US2016263110A1Use of masitinib for treatment of amyotrophic lateral sclerosisAB SCIENCE·Filed 2014·Application pending·0 cites
- 2751US2017196853A1Use of an inhibitor of kinase activity, particularly masitinib, for treatment of prostate cancerAB SCIENCE·Filed 2014·Application pending·0 cites
- 2850US2007249628A1Use of Mast Cells Inhibitors for Treating Patients Exposed to Chemical or Biological WeaponsMOUSSY ALAIN·Filed 2005·Application pending·0 cites
- 2950US2004242601A1Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitisFiled 2002·Application pending·0 cites
- 3050US2023089715A1Masitinib for the treatment of a multiple sclerosis patient subpopulationAB SCIENCE·Filed 2021·Application pending·0 cites
- 3150US2008004279A1Use of C-Kit Inhibitors for Treating Plasmodium Related DiseasesMOUSSY ALAIN·Filed 2005·Application pending·0 cites
- 3249US2016244845A1Method for determining the prognosis of pancreatic cancerAB SCIENCE·Filed 2014·Application pending·0 cites
- 3349US2004266797A1Use of potent,selective and non toxic c-kit inhibitors for treating tumor angiogensisFiled 2002·Application pending·0 cites
- 3449US2004259892A1Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms)Filed 2002·Application pending·0 cites
- 3549US2008242704A1Substituted Oxazole Derivatives and their Use as Tyrosine Kinase InhibitorsAB SCIENCE·Filed 2006·Application pending·0 cites
- 3648US2005222091A1Use of tyrosine kinase inhibitors for treating cns disordersMOUSSY ALAIN·Filed 2003·Application pending·0 cites
- 3747US2014051662A1Treatment of multiple myeloma with masitinibMOUSSY ALAIN·Filed 2012·Application pending·0 cites
- 3847US2007032521A1Use of c-kit inhibitors for treating type II diabetesAB SCIENCE·Filed 2004·Application pending·0 cites
- 3946US2014147415A1Treatment of mastocytosis with masitinibMOUSSY ALAIN·Filed 2011·Application pending·0 cites
- 4046US2023226043A1Use of masitinib for the treatment of coronavirus disease 2019 (covid-19)AB SCIENCE·Filed 2021·Application pending·0 cites
- 4146US2008025916A1Tailored Treatment Suitable for Different Forms of MastocytosisAB SCIENCE·Filed 2004·Application pending·0 cites
- 4246US2007191267A1Use of tyrosine kinase inhibitors for treating cerebral ischemiaAB SCIENCE·Filed 2004·Application pending·0 cites
- 4345US12472164B2Masitinib for the treatment of sickle cell diseaseAB SCIENCE·Filed 2020·Granted Nov 18, 2025·0 cites·17 claims
- 4445US2005203098A1Use of tyrosine kinase inhibitors for treating substance use disordersFiled 2003·Application pending·0 cites
- 4544US10045978B2Treatment of mastocytosis with masitinibAB SCIENCE·Filed 2015·Granted Aug 14, 2018·0 cites·18 claims
- 4644US2015290235A1Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infectionsAB SCIENCE·Filed 2013·Application pending·0 cites
- 4744US2008207572A1Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple MyelomaAB SCIENCE·Filed 2006·Application pending·0 cites
- 4843US7741335B2Use of tyrosine kinase inhibitors for treating inflammatory diseasesAB SCIENCE·Filed 2002·Granted Jun 22, 2010·0 cites·1 claims
- 4943US2005089838A1Method for identifying compounds that specifically deplete mast cellsFiled 2002·Application pending·0 cites
- 5042US2005176687A1Use of tyrosine kinase inhibitors for treating autoimmune diseasesFiled 2002·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alain Moussy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →